Clinical trials investigating the newly approved GLP-1RA semaglutide for the treatment of NASH are currently ongoing
Some studies show improved muscle fiber regeneration and a shorter time to regain function, but the efficacy in humans remains unknown
Someone with normal glucose regulation but significant adiposity might experience appetite changes quickly but modest initial scale movement
For those looking to enhance recovery, reduce inflammation, and support gut health, BPC-157 peptide has gained attention as a promising therapeutic compound
Implications of neurogenesis in depression through BDNF: rodent models, regulatory pathways, gut microbiota, and potential therapy
If your symptoms last longer than a few weeks, or if you notice blood in your stool, strong abdominal pain, fever, or unintentional weight loss, contact your healthcare provider